TRIP6 and ovarian carcinoma: In conclusion, this study revealed the expression profile of three candidate molecules: ABCC3, CPS1, and TRIP6, previously associated with MDR phenomena, in resistant and sensitive ovarian carcinoma cell lines and EOC patients.